Comparative Evaluation of Body Temperature Measurement Using the CardioWatch 287-2 in an Intensive Care Setting.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCorsano Health B.V.

About this trial

Fever is a common symptom in many health conditions, but current methods to monitor body temperature (BT) are either invasive, costly, or not continuous. The Corsano CardioWatch 287-2, a wristband that tracks multiple vital signs, offers a new way to monitor BT by measuring skin temperature and heat flux on the wrist. It uses a machine learning algorithm to predict BT in real-time. The device has shown good results when compared to other non-invasive temperature measurements, like tympanic (ear) temperature, in stroke patients. However, it hasn't yet been compared to the gold standard of invasive rectal temperature monitoring in a clinical setting. This study aims to test the accuracy of the Corsano CardioWatch 287-2 in measuring body temperature against rectal temperature monitoring in a clinical environment.

Eligibility criteria

Qualifiers

≥ 18 years old;

Able to provide consent

Administered at the ICU or recovery room of the Reinier de Graaf hospita

Disqualifiers

Unable to wear the Corsano CardioWatch 287 or Radius-T sensor due to reasons such as allergic reactions, wounds, amputations etc.;

Unable to receive rectal temperature monitoring;

Thermoregulatory problems or diseases;

Hyperthermia (>40°C);

Trial design

Treatments tested in this trial

  • Corsano CardioWatch 287-2

Treatment groups

120 Participants
are divided into 1 treatment group

Sponsors and collaborators